<DOC>
	<DOC>NCT02129322</DOC>
	<brief_summary>The study is designed to investigate the effect of adjuvant therapy by Sorafenib, Oxaliplatin and S-1 to prevent the tumor recurrence for hepatocellular carcinoma after liver transplantation</brief_summary>
	<brief_title>Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>hepatocellular carcinoma after liver transplantation Major organ (heart, lung and brain) function was normal Any active infectious process The presence of clinically confirmed extrahepatic metastasis Postoperative dysfunction of any organ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>